170 related articles for article (PubMed ID: 14747476)
21. Leukemogenesis by CBF oncoproteins.
Friedman AD
Leukemia; 1999 Dec; 13(12):1932-42. PubMed ID: 10602413
[TBL] [Abstract][Full Text] [Related]
22. The core binding factor (CBF) alpha interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFbeta-SMMHC are both required to slow cell proliferation.
Cao W; Adya N; Britos-Bray M; Liu PP; Friedman AD
J Biol Chem; 1998 Nov; 273(47):31534-40. PubMed ID: 9813068
[TBL] [Abstract][Full Text] [Related]
23. DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells.
Britos-Bray M; Sacchi N; Friedman AD
Leukemia; 1996 Jun; 10(6):984-90. PubMed ID: 8667656
[TBL] [Abstract][Full Text] [Related]
24. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.
Sood R; Talwar-Trikha A; Chakrabarti SR; Nucifora G
Leukemia; 1999 Mar; 13(3):348-57. PubMed ID: 10086725
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.
Qiao M; Shapiro P; Fosbrink M; Rus H; Kumar R; Passaniti A
J Biol Chem; 2006 Mar; 281(11):7118-28. PubMed ID: 16407259
[TBL] [Abstract][Full Text] [Related]
26. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
[TBL] [Abstract][Full Text] [Related]
27. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
28. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
29. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
[TBL] [Abstract][Full Text] [Related]
30. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation.
Brown C; Gaspar J; Pettit A; Lee R; Gu X; Wang H; Manning C; Voland C; Goldring SR; Goldring MB; Libermann TA; Gravallese EM; Oettgen P
J Biol Chem; 2004 Mar; 279(13):12794-803. PubMed ID: 14715662
[TBL] [Abstract][Full Text] [Related]
31. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the cyclin D3 promoter by E2F1.
Ma Y; Yuan J; Huang M; Jove R; Cress WD
J Biol Chem; 2003 May; 278(19):16770-6. PubMed ID: 12611887
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
[TBL] [Abstract][Full Text] [Related]
34. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.
Rhoades KL; Hetherington CJ; Rowley JD; Hiebert SW; Nucifora G; Tenen DG; Zhang DE
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11895-900. PubMed ID: 8876234
[TBL] [Abstract][Full Text] [Related]
35. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability.
Tanaka T; Kurokawa M; Ueki K; Tanaka K; Imai Y; Mitani K; Okazaki K; Sagata N; Yazaki Y; Shibata Y; Kadowaki T; Hirai H
Mol Cell Biol; 1996 Jul; 16(7):3967-79. PubMed ID: 8668214
[TBL] [Abstract][Full Text] [Related]
36. Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism.
Wang C; Hou X; Mohapatra S; Ma Y; Cress WD; Pledger WJ; Chen J
J Biol Chem; 2005 Apr; 280(13):12339-43. PubMed ID: 15713665
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
[TBL] [Abstract][Full Text] [Related]
38. AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
Yamaguchi Y; Kurokawa M; Imai Y; Izutsu K; Asai T; Ichikawa M; Yamamoto G; Nitta E; Yamagata T; Sasaki K; Mitani K; Ogawa S; Chiba S; Hirai H
J Biol Chem; 2004 Apr; 279(15):15630-8. PubMed ID: 14752096
[TBL] [Abstract][Full Text] [Related]
39. AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter.
Libermann TA; Pan Z; Akbarali Y; Hetherington CJ; Boltax J; Yergeau DA; Zhang DE
J Biol Chem; 1999 Aug; 274(35):24671-6. PubMed ID: 10455134
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
Hajra A; Liu PP; Speck NA; Collins FS
Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]